Cigna Group (CI) – Investment Analysts’ Weekly Ratings Updates

A number of research firms have changed their ratings and price targets for Cigna Group (NYSE: CI):

  • 10/2/2026 – Cigna Group had its “outperform” rating reaffirmed by Sanford C. Bernstein.
  • 10/2/2026 – Cigna Group was given a new $370.00 price target by Piper Sandler. They now have an “overweight” rating on the stock.
  • 10/2/2026 – Cigna Group had its price target raised by Piper Sandler from $346.00 to $370.00. They now have an “overweight” rating on the stock.
  • 10/1/2026 – Cigna Group had its “buy” rating reaffirmed by UBS Group AG.
  • 10/1/2026 – Cigna Group had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $337.00 price target on the stock.
  • 9/26/2026 – Cigna Group was upgraded by Wall Street Zen from “hold” to “buy”.
  • 9/12/2026 – Cigna Group was downgraded by Wall Street Zen from “buy” to “hold”.
  • 9/9/2026 – Cigna Group is now covered by Evercore Inc. They set an “in-line” rating and a $290.00 price target on the stock.
  • 8/29/2026 – Cigna Group was upgraded by Wall Street Zen from “hold” to “buy”.
  • 8/27/2026 – Cigna Group had its “hold (c)” rating reaffirmed by Weiss Ratings.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date was Tuesday, September 8th. Cigna Group’s dividend payout ratio is presently 25.82%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 in the last 90 days. 0.60% of the stock is currently owned by insiders.

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

Read More

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.